Trial
NCT01217814
Effect of SAR153191 (REGN88) With Methotrexate in Patients With Active Rheumatoid Arthritis Who Failed TNF-α Blockers
Phase IITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
Sanofi
Collaborators
Regeneron Pharmaceuticals
Condition
Rheumatoid Arthritis
Intervention
Sarilumab
Why stopped
Due to delay in the study and the impact on the development timelines, not due to any identified safety concerns
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2017-09-01